Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 309

    US patent court deals setback to Allergans Restasis strategy

    US patent court deals setback to Allergan's Restasis strategy

    Ruby Khatun Khatun28 Feb 2018 9:45 AM IST
    A U.S. administrative court said it has the authority to decide the validity of patents Allergan Plc transferred to a Native American tribe, dealing a...
    Judge rules against Pharma Bro on investor losses

    Judge rules against Pharma Bro on investor losses

    Ruby Khatun Khatun28 Feb 2018 9:30 AM IST
    NEW YORK: "Pharma Bro" Martin Shkreli was responsible for nearly $10.5 million in losses in a securities fraud scheme, a judge ruled Monday, a blow to...
    Shantha Biotechnics receives WHO nod for cholera vaccine storage

    Shantha Biotechnics receives WHO nod for cholera vaccine storage

    Ruby Khatun Khatun27 Feb 2018 10:45 AM IST
    New Delhi: Sanofi Pasteur said its affiliate Shantha Biotechnics has received approval from the World Health Organization for storage of its oral...
    Aster DM Healthcare shares down over 5 percent in debut trade

    Aster DM Healthcare shares down over 5 percent in debut trade

    Ruby Khatun Khatun27 Feb 2018 10:30 AM IST
    New Delhi: Shares of Aster DM Healthcare made a weak debut at the bourses, ending over 5 percent down from the issue price of Rs 190.The stock listed...
    Aurobindo Pharma eyes Apotex European business

    Aurobindo Pharma eyes Apotex European business

    Ruby Khatun Khatun27 Feb 2018 10:15 AM IST
    New Delhi: Aurobindo Pharma is reported to have shown an interest to buy European business of Canadian drugmaker Apotex.According to industry sources,...
    Startups revamping healthcare sector in India

    Startups revamping healthcare sector in India

    Ruby Khatun Khatun27 Feb 2018 10:00 AM IST
    New Delhi: With the rise in technology, there is a high demand for quality and affordable healthcare in India. The healthcare market in the country is...
    Online medical services portal awarded at CXO Summit

    Online medical services portal awarded at CXO Summit

    Ruby Khatun Khatun27 Feb 2018 9:45 AM IST
    New Delhi: Technology-driven online medical services platform IndiaVirtualHospital.com has been awarded for its innovative approach in the field of...
    KemPharms opioid painkiller gets FDA approval

    KemPharm's opioid painkiller gets FDA approval

    Ruby Khatun Khatun27 Feb 2018 9:30 AM IST
    KemPharm Inc said the U.S. Food and Drug Administration approved its opioid painkiller Apadaz for the short-term management of acute pain.The company...
    20 ayurvedic healthcare centres set up in 3 NE states

    20 ayurvedic healthcare centres set up in 3 NE states

    Ruby Khatun Khatun26 Feb 2018 10:30 AM IST
    Guwahati: At least 20 ayurvedic healthcare centres have recently been set up in Assam, Sikkim and Arunachal Pradesh, Union Minister Sripad Naik...
    India, Uzbek region ink pharma pact

    India, Uzbek region ink pharma pact

    Ruby Khatun Khatun26 Feb 2018 10:15 AM IST
    New Delhi: The Andijan Region of Uzbekistan and India have inked an agreement for cooperation in the pharmaceutical industry.A joint statement...
    Merck to buy Viralytics for 394 million dollars

    Merck to buy Viralytics for 394 million dollars

    Ruby Khatun Khatun26 Feb 2018 10:00 AM IST
    U.S. drugmaker Merck & Co, already one of the leaders in the hot area of cancer immunotherapy, said it had agreed to buy Viralytics for 502...
    Daiichi Sankyo initiates phase 1 study of DS-1062 in patients with advanced NSCLC

    Daiichi Sankyo initiates phase 1 study of DS-1062 in patients with advanced NSCLC

    Ruby Khatun Khatun26 Feb 2018 9:45 AM IST
    TOKYO, BASKING RIDGE, N.J. and MUNICH: Daiichi Sankyo announced the first patient has been dosed in a phase 1 study assessing the safety and...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok